AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis.
Deng B, Liu F, Chen N, Li X, Lei J, Chen N, Wu J, Wang X, Lu J, Fang M, et al. Cell Death Dis. 2024 Mar 23; 15(3):233. Epub 2024 Mar 23.